menopause and semaglutide Weight Gain During Menopause: Solutions in the Era of GLP1-agonists Tirzepatide vs Semaglutide for Microdosing

No surgery, no downtimejust a more confident, radiant you

Greco and colleagues reportedan enhancement in DNA damage in 76% of patients with moderate DNA damage (15%) after oral intake with vitamins [53]

These processes are controlled by SAM and SAH, which depend on vitamins B6, B9, and B12

The SURMOUNT trial program provides extensive data on what tirzepatide achieves without any additional weight loss medication: 5 mg dose: 15.0% average weight loss at 72 weeks 10 mg dose: 19.5% average weight loss at 72 weeks 15 mg dose: 20.9% average weight loss at 72 weeks At 15 mg, 56.1% of participants lost at least 20% of body weight At 15 mg, 38.7% of participants lost at least 25% of body weight These numbers are remarkable